Kate Jackson Hobbs

Kate Jackson Hobbs, CFA, is an accomplished equity research analyst and investment professional with extensive experience in the healthcare sector. Currently serving as a Vice President and Equity Research Analyst at T. Rowe Price since August 2020, Kate advises on $30 billion in investments across Medical Devices and Life Science Tools/Diagnostics, holding sole responsibility for a $3 billion sleeve of a Structured Research fund. Previously, Kate was a Portfolio Manager at Millennium, overseeing a $300 million market-neutral equity portfolio, and has held positions at Citadel, MFS Investment Management, and BlackRock, achieving top-tier performance in various roles. Additionally, Kate serves as a Board Observer for Galvanize Therapeutics, Inc. and Kardium Inc., and has experience as a Board Member for Rhythm, Rhyme, Results. Kate earned an MBA from the Stanford University Graduate School of Business and an A.B. in Psychology from Harvard University.